Ordinary Reweighting | Enhanced Consciousness Index | Effective Date 8th December 2022
In the ordinary rebalancing the following index composition will be implemented effective open 08.12.2022:
| ACADIA PHARMACEUTICALS INC |
| AIKIDO PHARMA INC |
| ALKERMES PLC |
| ATAI LIFE SCIENCES B.V |
| BIOGEN INC |
| COMPASS PATHWAYS PLC |
| DENALI THERAPEUTICS INC |
| GH RESEARCH PLC |
| H LUNDBECK AS |
| H LUNDBECK AS – Class B |
| INTRA-CELLULAR THERAPIES INC |
| JAZZ PHARMACEUTICALS PLC |
| JOHNSON & JOHNSON |
| MIND MEDICINE MINDMED INC |
| MYRIAD GENETICS INC |
| NEUROCRINE BIOSCIENCES INC |
| NEW BIOHAVEN |
| NRX PHARMACEUTICALS INC |
| RELMADA THERAPEUTICS INC. |
| SAGE THERAPEUTICS INC |
| SAREPTA THERAPEUTICS INC |
| SEELOS THERAPEUTICS INC |
| TONIX PHARMACEUTICALS HOLDIN |
| UCB SA |
| VISTAGEN THERAPEUTICS INC |
| ZYNERBA PHARMACEUTICALS INC |